Showing results (91-100 of 171) with videos related to
Sort By:
Pageof 18
Annals of Surgery|June 6, 2012
Pulmonary recurrence predominates after combined modality therapy for rectal cancer: an original retrospective studyPeirong Ding, David Liska, Peter Tang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2005
A phase I clinical trial of the sequential combination of irinotecan followed by flavopiridolManish A Shah, Jeremy Kortmansky, Monica Motwani, et al.Annals of Surgical Oncology|February 6, 2004
Residual mesorectal lymph node involvement following neoadjuvant combined-modality therapy: rationale for radical resection?Francesco Stipa, Alma Zernecke, Harvey G Moore, et al.Surgery|October 20, 2022
Endoscopic polypectomy for malignant polyps: Should tumor location (right versus left side) guide clinical decisions?Sonja Boatman, Sarah L Mott, Aasma Shaukat, et al.Operative Neurosurgery (Hagerstown, Md.)|August 20, 2024
Robotic Resection of Spinal and Paraspinal TumorsOri Barzilai, Alvin C Goh, Bernard Park, et al.JCO Precision Oncology|April 23, 2019
Majority of B2M-Mutant and -Deficient Colorectal Carcinomas Achieve Clinical Benefit From Immune Checkpoint Inhibitor Therapy and Are Microsatellite Instability-HighSumit Middha, Rona Yaeger, Jinru Shia, et al.The Annals of Thoracic Surgery|May 26, 2009
Prognostic factors for recurrence after pulmonary resection of colorectal cancer metastasesMark W Onaitis, Rebecca P Petersen, John C Haney, et al.Journal of the National Cancer Institute|February 26, 2015
Primary tumor location as a prognostic factor in metastatic colorectal cancerFotios Loupakis, Dongyun Yang, Linda Yau, et al.Journal of the National Cancer Institute|September 25, 2014
Comparison of tumor regression grade systems for locally advanced rectal cancer after multimodality treatmentAtthaphorn Trakarnsanga, Mithat Gönen, Jinru Shia, et al.Molecular Cancer Research : MCR|February 11, 2017
Chromosome 20q Amplification Defines a Subtype of Microsatellite Stable, Left-Sided Colon Cancers with Wild-type RAS/RAF and Better Overall SurvivalRyan N Ptashkin, Carlos Pagan, Rona Yaeger, et al.Pageof 18